The same is true for large drug companies, he said.
But the states are only part of the problem for drug companies.
It's not time to give in to the big drug companies.
Less than 10 percent of the money being raised tonight comes from drug companies.
The money usually comes from drug companies, but they need to get something out of it, she said.
But drug companies said the costs would be much higher.
And even if the government does order the change, the drug companies are almost certain to fight back in court.
A drug company is free to cut prices on its own.
The matter has put pressure on some big drug companies.
And the drug companies want to keep it that way.
There was once a pharmaceutical company that could do no wrong.
These days, it is often not enough for pharmaceutical companies simply to bring a drug to market.
A number of large traditional pharmaceutical companies are moving in as well.
That will be available to pharmaceutical companies - for a price.
Such studies are under way at several pharmaceutical companies, researchers said.
And a big pharmaceutical company is out to take it away from him.
Finally, no financial support should have been provided by a pharmaceutical company.
Are the doctors just playing the game of the big pharmaceutical companies?
We're also working with pharmaceutical companies to see if we can't help them make it available.
He was paid to be a subject in drug studies by a pharmaceutical company.
They must steer clear of any involvement with Western drug firms.
She went on to say that Perry also took campaign contributions from the drug firm.
I was thinking more about trying one of the big drug firms out in New Jersey.
There was no reason for a drug firm like Arolen to have such a complete file on a doctor.
And working as a detail man for a drug firm.
It turned out that many drug firms had large installations on the island.
Instead, only the top 200 officials must keep their holdings in any one drug firm below a $15,000 cap.
The provision of learning resources need not be costly, as many drug firms provide information free.
Yet the compromise makes sense even for drug firms.
"They should be given credit for the ability to show respectable growth when other drug firms are struggling."